利用18F-FDG PET/CT图像构建肿瘤体素剂量反应矩阵与剂量处方函数用于自适应剂量绘画
研究基于18例头颈癌患者化放疗前、中、后的FDG-PET/CT图像及治疗结果,构建肿瘤体素剂量反应矩阵和剂量处方函数,用于自适应剂量绘画(DPbN)。结果显示肿瘤体素剂量抵抗与基线SUV0无关,是局部失败的主要原因;多数HPV阴性肿瘤某些区域需>100 Gy剂量,自适应DPbN计划临床可行。
要点
- 基于系列FDG-PET/CT构建肿瘤体素剂量反应矩阵与体素控制概率查找表。
- 肿瘤体素剂量抵抗与基线SUV0无相关性,是肿瘤局部失败的主要原因。
- 自适应DPbN联合FDG-PET/CT反馈在临床实施可行。
核心结论
- 肿瘤体素(SUV0,DRM)提供瘤内预后图谱以靶向肿瘤局部区域抵抗区。
- 相应的TVCP或DPF提供定量目标以优化个体瘤内剂量分布。
- 基于FDG-PET/CT成像反馈的自适应DPbN在临床实施可行。
研究设计与样本
- 建模使用18例头颈癌患者化放疗前、化放疗期间每周及化放疗后的FDG-PET/CT图像以及治疗结果。
- 所有每周及治疗后PET/CT图像与相应治疗前基线PET/CT图像进行体素对体素配准。
主要发现
- 肿瘤体素(SUV0,DRM)存在大的肿瘤间和瘤内变异。
- 肿瘤体素剂量抵抗与其基线SUV0值无相关性,是肿瘤局部失败的主要原因。
- 肿瘤体素DPF作为肿瘤体素(SUV0,DRM)值的函数也显示非常大的肿瘤间和瘤内异质性。
- 多数人乳头瘤病毒阴性肿瘤的某些局部肿瘤区域需要>100 Gy的治疗剂量。
- 这些治疗剂量在传统放疗中最不可能实现,但可通过自适应DPbN治疗达到。
关键数值与推荐
- 肿瘤体素控制概率(TVCP)查找表通过最大似然估计在所有肿瘤的肿瘤体素(SUV0,DRM)域上创建。
- 肿瘤体素DPF由TVCP查找表创建,并用作基于DPbN的逆向计划优化的目标函数。
- 临床可行性通过比较自适应DPbN治疗计划与传统调强放疗计划进行评估。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To construct a tumor voxel dose response matrix (DRM) and dose prescription function (DPF) for adaptive dose painting by number (DPbN) based on treatment feedback of fluoro-2-deoxyglucose (FGD) positron emission tomography (PET)/computed tomography (CT) imaging. METHODS AND MATERIALS: FDG-PET/CT images obtained before and after chemoradiation therapy and at weekly chemoradiation therapy sessions for each of 18 patients with head and neck cancer, as well as the treatment outcomes, were used in the modeling. All weekly and posttreatment PET/CT images were registered voxel-to-voxel to the corresponding pretreatment baseline PET/CT image. Tumor voxel DRM was created using serial FDG-PET imaging of each patient with respect to the baseline standardized uptake value (SUV0). A tumor voxel control probability (TVCP) lookup table was created using the maximum likelihood estimation on the tumor voxel (SUV0, DRM) domain of all tumors. Tumor voxel DPF was created from the TVCP lookup table and used as the objective function for DPbN-based inverse planning optimization. RESULTS: Large intertumoral and intratumoral variations on both tumor voxels (SUV0, DRM) were identified. Tumor voxel dose resistance did not show correlation with its baseline SUV0 value and was the major cause of the tumor local failures. Tumor voxel DPF as the function of tumor voxel (SUV0, DRM) values also showed a very large intertumoral and intratumoral heterogeneity. Most human papillomavirus-negative tumors require a treatment dose >100 Gy to certain local tumor regions. These treatment doses, which are most unlikely to be implementable in conventional radiation therapy, can be achieved using adaptive DPbN treatment. Clinical feasibility was evaluated by comparing the adaptive DPbN treatment plan with the conventional intensity modulated radiation therapy plan. CONCLUSIONS: Tumor voxel (SUV0, DRM) provides an intratumoral prognostic map to target tumor locoregional-resistant regions. The corresponding TVCP or DPF provides a quantitative objective to optimize the intratumoral dose distribution for the individuals. The adaptive DPbN with FDG-PET/CT imaging feedback is feasible to implement in clinics.
引用
- Yan D, Chen S, Krauss DJ, et al. Tumor Voxel Dose-Response Matrix and Dose Prescription Function Derived Using 18F-FDG PET/CT Images for Adaptive Dose Painting by Number. Int J Radiat Oncol Biol Phys. 2019. PMID: 30684661. doi:10.1016/j.ijrobp.2019.01.077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。